The purpose of this study was to define the pattern of postnatal plasma cortisol concentrations during the first week of life in premature infants, and to evaluate the effect of developmental and clinical factors on this pattern. We measured plasma cortisol concentrations in the morning and afternoon on d 2, 4, and 6 in 120 premature infants (gestational age 24-36 wk) and examined the effects of gestational age, postnatal age, and illness. We described an inverse relationship between gestational age and cortisol concentrations, with the youngest infants having the highest random cortisol values (F = 5.14, p = 0.0073). Illness had a significant negative effect such that the cofactors ventilatory support pattern (F = 6.62, p = 0.0016) or "use of surfactant" (F = 6.63, p = 0.001) defined a pattern where cortisol values were lower in infants that had the highest ventilatory requirements or that received surfactant compared with values from those infants who did not have these requirements. The postnatal pattern in cortisol values depended on gestational age.
I11 infants more than 27 wk gestational age increased their cortisol values from d 2 to d 6 although cortisol values decreased in well infants. These patterns resulted in a nonsignificant change over time for these age groups. In contrast, cortisol values significantly decreased from d 2 to d 6 in both well and ill infants that were less than or equal to 27 wk. We conclude that plasma cortisol concentrations in the premature infant are significantly correlated with gestational age and to markers of illness. Interpretation of the physiologic significance of random cortisol values in this patient population must be made with consideration for the statistically significant effects described above. (Pediatr Res 37: 112-116, 1995) Abbreviations ELBW, extremely low birth weight CBG, cortisol-binding globulin RAS, respiratory acuity score Recent studies have reported an association between low random cortisol values, clinical signs consistent with adrenal insufficiency, and resolution of these findings with cortisol supplementation in the ELBW infant (1, 2) . The authors of these studies suggested that the ELBW infant is at increased risk for adrenal insufficiency; however, there is limited information for cortisol values in these infants. Doerr et al. (3) reported that the well infant of more than 32 wk gestation has a significant decrease in cortisol from birth and that values at 7 d are similar to those of full-term infants. This information is not available for more immature or sick premature infants.
Metzger et al. (4) recently reported in a small number of premature infants in whom the ultradian (pulsatility within 24-h cycle) pattern of plasma cortisol concentrations had a higher baseline and lower amplitude than that seen in the full-term infant. That study and the report by Hanna et al. (5) that the ill premature infant has elevated corticotropinreleasing hormone concentrations in comparison with the adult raise concerns about the adequacy of the hypothalamicpituitary-adrenal axis in the ELBW infant, in particular during periods of illness.
The purpose of this study was to define the pattern of postnatal plasma cortisol concentrations during the first week of life in premature infants and to evaluate the effect of developmental and clinical factors on this pattern.
METHODS

Subjects.
All appropriate for gestational age infants less than 37 wk gestational age admitted to the newborn intensive care unit at the Children's Hospital of New Mexico were eligible for the study. No infants were of diabetic mothers, nor were they large or small for gestational age. Infants were enrolled after informed consent was obtained from the parents or guardians. RESULTS To avoid the effects of the surge at birth On the Subjects. Table 1 shows the population characteristics of the postnatal cortisol pattern, blood samples for cortisol measure-178 infants enrolled in the Matched cortisol samples in merits were collected in the morning and afternoon of d 2, 4, the morning and afternoon on each day resulted in a sample and mL per Morning On and (0.3 size of 120 for statistical evaluation. The distribution of girls mL/sam~le) were for CBG examine the and boys was not significantly different in any gestational age relationship of cortisol to CBG.
group. There was a significant decrease in surfactant use with Baseline information obtained on each infant included ges-increasing gestational age (group 1,78%; group 2, 60%; group tational age, sex, and use of exogenous surfactant. Clinical data 3, 50%; = 0.017). Infants were distributed in the three RAS collected on the same days as the blood samples included "use groups as shown. The choice of definitions for the RAS groups of inotropes" and maximum ventilator settings each day. The excluded four infants whose clinical course did not follow the magnitude of respiratory support was estimated with RAS, a described patterns. The use of inotropes and surfactant was clinical score shown to correlate well with estimates of respi-also significantly correlated with RAS group, with the highest ratory disease that incorporates blood gas data (6) . RAS is the use of these therapies in RAS group 111 ( Table 2) . sum of the whole numbers for oxygen concentrations greater Cortisol pattern. The first model evaluated was cortisol than 25% (adjusted for altitude at the study site), positive end concentrations on postnatal age. We began by evaluating the expiratory pressure (cm H,O), peak inspiratory pressure (cm Presence of a diurnal Pattern. We used 1% transformation after H,o), and mechanical breaths per minute (e,g. a patient on initial examination of the paired t test relationship of morning 50% o,, [21/41 pressures, and an intermittent mandatory ven-to afternoon absolute cortisol values demonstrated a significant tilation rate of 30 would have a US of 80). Three difference but generated a residual plot that suggested lack of groups were prospectively defined to reflect the expected pat-a normal distribution. Using log,, values, the data had a normal terns of respiratory support during the first week of life. Group distribution. I included infants who had an RAS value less than 80 on d 2
The difference between morning and afternoon cortisol values was more than 0 on d 2 (F(,,,,,) = 4.68, p = 0.01). This and 6. Group I1 consisted of infants who had an RAS value of result suggested that on d 2, cortisol values may be greater in than On and less than by 67 and ' I1 the morning than afternoon. As such, the morning and afterincluded infants with an RAS value greater than 80 on both noon values on each day could not be averaged but were days. studied separately.
Measurements. Cortisol values were measured using the
We found no significant changes from d 2 to d 6 using either Diagnostic Corporation kit (Los Angeles, CA) with duplicate morning or afternoon cortisol values or sex in the model of samples. The intraassay and interassay variabilities for the cortisol concentrations on postnatal age. The cofactors of assay were 5.6 and 7.5%, respectively. Cross-reaction for all gestational age, RAS group, and "use of surfactant" each naturally occurring adrenal steroids is less than 0.1%. Cortisol significantly added to the description using afternoon values. values were converted from pg/dL to nmol/L by multiplying Gestational age was the most significant single factor in exby a factor of 27.6. CBG values were measured at the Nichols plaining the variability (F(,,,,,) = 5.14, p = 0.0073). ThereInstitute Reference Laboratories (San Juan Capistrano, CA).
fore, we changed the model to cortisol concentrations on Statistics' data were using the gestational age. The resulting pattern was such that the younger Institute, Inc., Cary, NC) statistical package in the General the infant the higher the cortisol value. Postnatal age, RAS Clinical Research Center at the University of New Mexico, group, use of surfactant, and use of inotropes then became School of Medicine. The study was designed to evaluate a cofactors. model of cortisol on postnatal age with gestational age, RAS
The model was designed to analyze the effect of illness on group, sex, "use of surfactant," and "use of inotropes" as cortisol concentrations using three indicators of illness: use of cofactors using analysis of variance and repeated measures exogenous surfactant and inotropes as markers of acute illness analysis of variance. When gestational age was later chosen as and RAS groups to define the pattern of illness over the first 6 the independent variable, postnatal age became a cofactor. d of life. In a model of cortisol on gestational age with Initial evaluation used gestational age as a continuous variable. surfactant as a cofactor, we found that gestational age (F(,,,,,) The between gestational age and with = 6.71,p = 0.0012) and surfactant (F(,,,,,, = 6.63, = 0.001) surfactant or inotropes as cofactors was statistically significant, but the cells necessary for the statistical evaluation became cumbersome. We reviewed the results for likely breakpoints in had independent significant effects such that infants treated with surfactant had lower cortisol values than those not receiving this therapy (Fig. 1) . Data from afternoon cortisol values on each day were included in the analysis. The use of inotropes as a cofactor resulted in a significant pattern similar to that seen with surfactant (F(,,,,,) = 4.00, p = 0.01).
Infants who failed to resolve their early lung disease (RAS group 111) had significantly lower cortisol values than those found in the other groups of infants (F(2,238) = 6.62, p = 0.0016) (Fig. 2) .
We found that postnatal age had an interactive effect with gestational age and surfactant (F(,,,,,) = 4.17, p = 0.017). Using a model that included all infants, postnatal age had no significant main effect separate from that noted for gestational age and use of surfactant. The interactive effect was further studied by examining the cortisol pattern within the three gestational age groupings with the model cortisol on postnatal age with surfactant as a cofactor (Fig. 3) . For all three gestational age groups, cortisol values decreased from d 2 to 6 in infants not receiving surfactant, although the changes were not significant. For groups 2 and 3, cortisol values increased from d 2 to 6 for those infants receiving surfactant, and thus the patterns for those receiving surfactant and those who did not interact across time resulting in a nonsignificant difference. In contrast, in group 1 (24-27 wk), both surfactant-treated and untreated infants decrease their cortisol values from d 2 to 6 (F(2,25) = 3.96 p = 0.03). CBG. There were 61 infants included in the analysis of CBG. The gestational age distribution for this subset was similar to that for the entire group. Mean CBG concentration (16 f 5 mg/L) was less than the adult normal range (19-45 mg/L). There was a trend for younger infants to have lower CBG values, but there was no significant change with gestational age.
DISCUSSION
We have described the effects of gestational age, postnatal age, and illness on plasma cortisol concentrations in a group of preterm infants. Although previous investigators have reported higher plasma cortisol concentrations in premature infants compared with term infants (7), this is the first study to demonstrate an inverse correlation of gestational age and a concomitant significant negative effect of illness on cortisol values.
We found an inverse relationship between gestational age and cortisol values. The expected higher incidence of illness (higher RAS group) in the more immature infants did not eliminate the gestational age effect, but rather RAS group category was negatively correlated with cortisol values. The net result was that a 24-to 27-wk-old infant had a higher random cortisol value than did the clinically equivalent 32-to 36-wk old infant. The physiologic significance of this inverse correlation is unclear. If we postulate that the gestationally older infant has more mature control over baseline cortisol values, then a "high" cortisol value in an immature infant may not necessarily reflect an appropriate response. The recent reports of altered growth hormone (8) and cortisol ultradian (4) patterns in premature infants combined with our results are consistent with a state of immature feedback regulation in the premature infant. An alternative speculation may be that there is decreased tissue sensitivity to cortisol requiring higher cortisol concentrations for normal cortisol action. The other two markers of illness (use of exogenous surfactant and inotropes) delineated an effect that was also statistically important and independent of the effect of gestational age. Thus, infants who received surfactant (or inotropes) had significantly lower cortisol values compared with the same gestational-aged infants that were well enough to not receive the medications. These factors allowed us to compare the acutely sick versus well infant. Whereas the adult in an intensive care unit has higher cortisol values compared with nonstressed controls (9), this was not the pattern in our study.
The low cortisol values we described may be of clinical significance. Cortisol values were the lowest in those infants who required inotropic support and surfactant, and this relationship was present across gestation. The association of surfactant and inotrope use with lower plasma cortisol values may reflect inadequate cortisol secretion for the production and release of surfactant, and for adequate cardiac function (10) .
The lower cortisol values could not be explained by CBG values. The lower values in premature infants compared with adults were only slightly below the adult range. Furthermore, combining the inverse relationship of cortisol with gestational age and lower CBG values in younger infants would result in higher free cortisol values in the younger infants.
Our studies were designed to define the postnatal cortisol ontogeny in premature infants. On d 2, there appeared to be a diurnal pattern that was absent after that time. The need for multiple samples to rule out a diurnal pattern means that a significantly lower cortisol value on other days could have been missed. The wide individual variability in cortisol values is consistent with the concept that the magnitude of individual cortisol values after d 2 was probably random and not under mature central feedback regulation.
We found that the effect of postnatal age on cortisol values resulted from an interactive rather than a main effect. This appeared to be due to the heterogeneity of the patient population in its cortisol response. Cortisol values decreased from d 2 to d 6 in all infants who did not receive surfactant and who were thus interpreted as having less significant lung disease. This is similar to the pattern seen in full-term nonstressed infants, in whom the nadir of plasma cortisol is seen at 4 d. In infants who were more than 27 wk gestational age and who received surfactant, cortisol values increased from d 2 to d 6 as would be desired in response to illness. Concomitantly, 68 of 77 infants who received surfactant were resolving their lung disease by d 6 (infants in RAS groups I and 11). The resulting intersecting cortisol pattern for well versus ill infants produced a nonsignificant change over time for each gestational age group and showed the "expected" pattern of cortisol values for each subgroup. However, in the youngest gestational age group, cortisol values decreased in infants who received surfactant. Fifty percent (15 of 30) of these infants failed to improve their lung disease by d 6 (RAS group 111). Thus, values decreased in both well and sick infants, and the change over time was significant.
In summary, the pattern of cortisol concentrations in the premature infant was significantly correlated with gestational age, with the youngest infants having the highest cortisol values, and inversely correlated with markers of illness. We suggest that the need for surfactant and inotropes and the failure to resolve ventilation needs in premature infants may be due, in part, to clinically inadequate cortisol availability. Gestational age group 1 (24-27 wk) may be at greatest risk. This group of infants had the highest baseline values, which were combined with incidence of significant illness and had a significant decrease in cortisol values across time. By d 6, 50% of the infants were not resolving their lung disease, whereas only 12% of older infants are not improving. This possibility was further emphasized by the difference in the need for inotropic support within gestational age group 1 when compared by RAS group. Eight percent of infants in RAS I were on inotropic support on d 4 or 6, whereas 22 and 87% of RAS groups I1 and 111, respectively, were still on inotropic support. We suggest that the decreased efficiency of both production (known to be present in premature infants) and maintenance of high baseline values (or decreased sensitivity at the tissue level) combined with decreasing cortisol values in a setting of continued illness defined a group of infants who expressed a high incidence of cortisol insufficiency. Studies that compare these markers and potential signs of adrenal insufficiency with ACTH-stimulated release of cortisol in a model that includes gestational age will be necessary to further evaluate the clinical significance of our findings.
